Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-059668
Filing Date
2013-11-07
Accepted
2013-11-07 16:43:47
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v359133_10q.htm 10-Q 283627
2 EXHIBIT 31.1 v359133_ex31-1.htm EX-31.1 9619
3 EXHIBIT 31.2 v359133_ex31-2.htm EX-31.2 9618
4 EXHIBIT 32.1 v359133_ex32-1.htm EX-32.1 4100
5 EXHIBIT 32.2 v359133_ex32-2.htm EX-32.2 4103
  Complete submission text file 0001144204-13-059668.txt   1838610

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20130930.xml EX-101.INS 163684
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20130930.xsd EX-101.SCH 22257
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20130930_cal.xml EX-101.CAL 33433
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20130930_def.xml EX-101.DEF 43394
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20130930_lab.xml EX-101.LAB 269099
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20130930_pre.xml EX-101.PRE 115405
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 131201185
SIC: 2836 Biological Products, (No Diagnostic Substances)